In recent years, there has been a rise in the number of whistleblowers coming forward to report securities fraud and file whistleblower lawsuits. The significance of these whistleblowers has increased over time, and their prevalence is projected to continue increasing as a result of recent legislation by Congress. Any company or individual that has been a victim of securities fraud must consider their legal options before moving forward. While there are many different ways you can respond if you discover that you have been the victim of illegal stock trading, an SEC whistleblower lawsuit is not always your best option. This article details some of the top reasons why SEC whistleblower lawsuits are worth pursuing when you have been the victim of securities fraud.

​In addition to serving justice, with a whistleblower lawsuit, you may also be entitled to a financial reward commonly known as whistleblower rewards. Many whistleblowers are entitled to 10% to 30% of the total financial penalties that are collected from the accused parties. Some whistleblowers have received $100 million+ in whistleblower rewards after filing an SEC whistleblower lawsuit. If you are concerned about the cost of hiring a lawyer to pursue your rights as a whistleblower, contact Nashville Whistleblower attorney Timothy L. Miles.

​In many cases, the fraud is committed by a large corporation, and it is not clear who you should hold responsible. A large company has many employees, and you may have no idea who was responsible for the fraud. The complaint that you file in an SEC whistleblower lawsuit can name specific individuals as responsible for the fraud. This allows you to hold individuals responsible for their actions, rather than the vague entity of a large company. You can also use your whistleblower lawsuit to request that certain people be investigated or fired from the company.

​​A common concern with reporting the fraud to the government is that the government will take action against the company, hurting the value of the stock. While this is generally a valid concern, it is not an option you are forced to choose. If you file an SEC whistleblower lawsuit against the perpetrators, you can help the stock value by increasing investor confidence and trust. Investor confidence increases as the fraud become exposed and the perpetrators are punished for their illegal activities. This benefits you, as you are likely to receive a whistleblowers award for your efforts.

​Securities fraud is a real problem that can impact investors of all types. An SEC whistleblower lawsuit may be the best way to proceed. If you are thinking of blowing the whistle, contact Nashville 8 Timothy L. Miles today for a free case evaluation.

The Inotiv class action lawsuit seeks to represent purchasers or acquirers of Inotiv, Inc. (NASDAQ: NOTV) securities between September 21, 2021 and June 13, 2022, inclusive (the “Class Period”).  The Inotiv class action lawsuit – captioned Grobler v. Inotiv, Inc., No. 22-cv-00045 (N.D. Ind.) – charges Inotiv and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
​
If you suffered losses in Inotiv stock and wish to serve as lead plaintiff of the Inotiv class action lawsuit, please provide your information below.  You can also contact Inotiv Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com.  Lead plaintiff motions for the Inotiv class action lawsuit must be filed with the court no later than August 22, 2022. If you have questions, please contact ​Inotiv Stock Loss Lawyer Timothy L. Miles today.

Inotiv purports to be a contract research organization which provides nonclinical and analytical drug discovery and development services and research models and related products and services.  On November 5, 2021, Inotiv completed its acquisition of Envigo RMS, LLC (“Envigo”) which is now a direct, wholly owned subsidiary of Inotiv.
​
The Inotiv class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) Envigo and Inotiv’s Cumberland, Virginia facility engaged in widespread and flagrant violations of the Animal Welfare Act of 1966 (“AWA”); (ii) Envigo and Inotiv’s Cumberland facility continuously violated the AWA; (iii) Envigo and Inotiv did not properly remedy issues with regards to animal welfare at the Cumberland facility; (iv) as a result, Inotiv was likely to face increased scrutiny and governmental action; (v) Inotiv would imminently shut down two facilities, including the Cumberland facility; (vi) Inotiv did not engage in proper due diligence; and (vii) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

​On May 20, 2022, Inotiv announced the search and seizure at its Cumberland facility and the filing of a United States Department of Justice complaint “alleging violations of the Animal Welfare Act at the Cumberland, Virginia facility.”  The following day, on May 21, 2022, Judge Moon of the United States District Court for the Western District of Virginia issued a temporary restraining order which stated the following pertinent details regarding the Cumberland facility: “Over 300 beagle puppies have died onsite due to ‘unknown causes’ over seven months;” “[n]ursing female beagles were denied food, and so they (and their litters) were unable to get adequate nutrition;” “[o]ver an eight-week period, 25 beagle puppies died from cold exposure;” “[p]erhaps the most heinous discovery of the November 2021 inspection was that Envigo had allowed staff to euthanize dogs without anesthesia, in violation of the facility’s own program of care;” and “[t]he Government contends that Envigo has consistently failed, despite repeated warnings and opportunities for correction, to meet its obligations under AWA’s implementing regulations to provide adequate veterinary care . . . [b]ased on the overwhelming evidence produced by the Government, the Court agrees.”  On this news, Inotiv’s share price fell by approximately 28%.

Then, on June 13, 2022, Inotiv announced the closing of two Envigo facilities – the purpose-bred canine facility in Cumberland and a rodent breeding facility in Dublin – mere months after the acquisition.  On this news, Inotiv’s share price fell an additional 2%, further damaging investors ​who suffered losses in Inotiv stock.

​The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in Terra Tokens to seek appointment as lead plaintiff in the Inotiv class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the class action lawsuit.  An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in Inotiv stock, and have further questions, contact ​Inotiv Stock Loss Lawyer Timothy L. Miles today.

​An ​Inotiv Stock Loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation. An ​Inotiv Stock Loss Lawyer focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, if they have lost money due to mistakes, incompetence, or fraud by an investment professional.  While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discovery every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct, such as an ​Inotiv Stock Loss Lawyer who will work to recover the losses you sustained.​

​​If you suffered significant losses in Inotiv stock, contact Inotiv Stock Loss Lawyer Timothy  L. Miles today about a Inotiv class action lawsuit​, and see what a ​Inotiv Stock Loss Lawyer can do for you.

The 17 Education & Technology class action lawsuit seeks to represent purchasers or acquirers of 17 Education & Technology Group Inc. (NASDAQ: YQ) publicly traded securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with 17 Education & Technology’s December 4, 2020 initial public offering (the “IPO”).  The 17 Education & Technology class action lawsuit – captioned Zhang v. 17 Education & Technology Group Inc., No. 22-cv-04937 (C.D.Cal.) – charges 17 Education & Technology and certain of its top executives, directors, and underwriters with violations of the Securities Act of 1933.
​
​​If you suffered losses in 17 Education & Technology and wish to serve as lead plaintiff of the 17 Education & Technology class action lawsuit, please provide your information below.  You can also contact 17 Education & Technology Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com.  Lead plaintiff motions for the ​17 Education & Technology class action lawsuit must be filed with the court no later than September 29, 2022. If you have questions, please contact ​17 Education & Technology Stock Loss Lawyer Timothy L. Miles today.

17 Education & Technology offered tutoring services related to academic subjects to students from kindergarten through the last year of senior high school (“K-12 Academic AST Services”) in the People’s Republic of China (“PRC”).  On December 4, 2020, 17 Education & Technology held its IPO, issuing approximately 27,400,000 American Depositary Shares (“ADSs”) to the investing public at $10.50 per ADS, pursuant to the Registration Statement.

​PRC authorities have been targeting private education companies and tutoring companies, especially including those that are Western-financed, for reform publicly since at least February 2019.  In January 2021, the month after the IPO, Chinese authorities publicly made clear within the PRC, again, that they would reform the private tutoring industry in which 17 Education & Technology operated.  In doing so, for example, the Central Commission for Discipline Inspection, the highest internal enforcement division of the Chinese Communist Party, and the National Supervision Commission of the PRC released an article warning about reforms of abuses by private education companies.  In light of the proposed, discussed, and enacted reforms from and connected to the 2018-2022 plan for modernizing Chinese education, several other Chinese education technology firms, including VIPKid, Huohua Siwei, Zuoyebang, and Yuanfudao, reportedly scrapped or postponed plans for initial public offerings.
​
The 17 Education & Technology Group class action lawsuit alleges that the IPO’s Registration Statement was false and/or misleading and/or failed to disclose that: (i) 17 Education & Technology’s K-12 Academic AST Services would end less than a year after the IPO; and (ii) as part of its ongoing regulatory efforts, Chinese authorities would imminently curtail and/or end 17 Education & Technology’s core business.

On July 23, 2021, mere months after the IPO, Chinese authorities formally revealed to the public continued regulations which banned after-school tutoring companies that teach the school curriculum from making profits, raising capital, or going public.  These measures formally ended any potential growth in the for-profit tutoring sector in the PRC. As of July 13, 2022, the price of 17 Education & Technology ADS has fallen by approximately 85% from the $10.50 IPO price, as investors sussered losses in 17 Education & Technology.

​The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in 17 Education & Technology to seek appointment as lead plaintiff in the 17 Education & Technology class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the class action lawsuit.  An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in 17 Education & Technologs, and have further questions, contact 17 Education & Technology Stock Loss Lawyer Timothy L. Miles today.

​A 17 Education & Technology Stock Loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation. A 17 Education & Technology Loss Lawyer focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, if they have lost money due to mistakes, incompetence, or fraud by an investment professional. While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discovery every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct, such as a 17 Education & Technology Stock Loss Lawyer who will work to recover the losses you sustained through a 17 Education & Technology Class Action lawsuit.​ Contact 17 Education & Technology Stock Loss Lawyer Timothy L. Miles today.

​If you suffered losses in 17 Education & Technology, contact ​17 Education & Technology Stock Loss Lawyer Timothy L. Miles today about a 17 Education & Technology class action lawsuit​, and see what a 17 Education & Technology Stock Loss Lawyer can do for you.

​On February 27, 2012 Abbott Laboratories, Inc. “(Abbott”) announced it was recalling powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Michigan, one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas. Products made at this facility can be found across the U.S. and were likely exported to other countries as well. Canadian health officials have also issued a recall warning.
​
Abbott is recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.  The Company said its EleCare Baby Formula Recall investigation is ongoing. If you have questions contact an EleCare Recall Lawyer for free about an Elecare Lawsuit by submitting the contact form at the bottom of the page. Read on to learn more about the EleCare Baby Formula Recall Lawsuit.

​The same day, the U.S. Food and Drug Administration (“FDA”) announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections. The FDA stated that in all of the cases are reported, each consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, Michigan facility. The FDA further stated it was is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility.
The FDA is advises consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

• the first two digits of the code are 22 through 37; and
• the code on the container contains K8, SH or Z2; and
• the expiration date is 4-1-2022 (APR 2022) or later.

​The FDA stated it was investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA stated it has initiated an onsite inspection at the facility and its findings to date include several positive Cronobacter sakazakii results from environmental samples taken and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicates environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.

In addition to the above, on February 28, 2012 Abbott additionally stated it was recalling one lot of Similac PM 60/40 (Lot # 27032K80 (can) / Lot # 27032K800 (case)) manufactured in Sturgis, Michigan.

To find out if your baby formula is subject to the recall, look on the bottom of the container for a product code that includes eight numbers or letters.

​In addition to the above, on February 28, 2012 Abbott additionally stated it was recalling one lot of Similac PM 60/40 (Lot # 27032K80 (can) / Lot # 27032K800 (case)) manufactured in Sturgis, Michigan.

To find out if your baby formula is subject to the recall, look on the bottom of the container for a product code that includes eight numbers or letters.

Then go to this website – www.similac.com/recall – where you can type in the code to see if your baby formula is on the list of Recalled Baby Formula. If you have additional questions or need assistance, contact EleCare Recall Lawyer Timothy L. Miles for free who will answer any questions you may have about an ​EleCare Baby Formula Recall Lawsuit.

​The recalled baby formula products contain bacteria that, if ingested, can cause a serious, life-threatening infection in young children. Any family that has Abbott products in their home should dispose of them and find a safer alternative for their children, one that will not jeopardize their health and well-being. Although there are only four cases of infections, it is best to avoid the products entirely to ensure your child's safety.

​Cronobacter sakazakii is a bacteria commonly found in dry environments, like baby formula, and can cause stomach issues as well as urinary tract infections in people of all ages. However, when it’s ingested by a child two months or younger, it can result in more serious infections, like sepsis and meningitis. If your child exhibits any of the following symptoms after consuming a dry food product, you should seek medical treatment to ensure their safety:

• Fever
• Unusual patterns of crying
• Abnormally low energy
• Difficulty or refusal to eat

On the other hand, Salmonella Newport causes symptoms of foodborne illness, such as diarrhea, intestinal pressure, and vomiting. This type of bacteria is significantly more dangerous to children under three months of age, and an infant who’s infected with Salmonella Newport will exhibit the same symptoms as Cronobacter sakazakii.

​If you notice that your child is exhibiting any of the symptoms mentioned above after consuming a powdered baby formula product, it is best to bring them to a trusted medical professional for a second opinion. The signs of a Cronobacter sakazakii or Salmonella Newport infection are very vague, and the behavior your child is showing could just be a coincidence rather than a severe diagnosis. However, you don’t want to leave that up to chance, and by seeking medical attention sooner rather than later, you can protect your child from the consequences of an infection that’s gone too far.

​If you or a loved one had an infant that was or is hospitalized because of using Recalled EleCare Baby Formula, specifically, Similac Baby Formula, Alimentum Baby Formula, or EleCare Baby Formula, which were purchased after August 2021, then you should be eligible for an EleCare Lawsuit.  Contact EleCare Recall Lawyer Timothy L. Miles today at (855) Tim-M-Law or complete the form below, you could be entitled to an Elecare Lawsuit and substantial compensation.

​If your baby was hospitalized after using EleCare Recalled Baby Formula purchased after August 2021, call EleCare Recall Lawyer Timothy L. Miles about a EleCare Baby Formula Recall Lawsuit today and see what a EleCare Recall Lawyer can do for you. The call is free and an EleCare Recall Lawyer is available 24/7 to speak with you about whether you are eligible for an EleCare Lawsuit.  

​On February 27, 2012 Abbott Laboratories, Inc. “(Abbott”) announced it was recalling powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Michigan, one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas. Products made at this facility can be found across the U.S. and were likely exported to other countries as well. Canadian health officials have also issued a recall warning.
​
Abbott is recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.  The Company said its Alimentum Baby Formula Recall investigation is ongoing. If you have questions, or would like to know more about the Alimentum Baby Formula Recall Lawsuit, contact Alimentum Recall Lawyer ​Timothy L. Miles for free today.

The same day, the U.S. Food and Drug Administration (“FDA”) announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections. The FDA stated that in all of the cases are reported, each consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, Michigan facility. The FDA further stated it was is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility. 

The FDA is addvides consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

• the first two digits of the code are 22 through 37; and 
• the code on the container contains K8, SH or Z2; and 
• the expiration date is 4-1-2022 (APR 2022) or later.

​The FDA stated it was investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA stated it has initiated an onsite inspection at the facility and its findings to date include several positive Cronobacter sakazakii results from environmental samples taken and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicates environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.  

​In addition to the above, on February 28, 2012 Abbott additionally stated it was recalling one lot of Similac PM 60/40 (Lot # 27032K80 (can) / Lot # 27032K800 (case)) manufactured in Sturgis, Michigan.
 
To find out if your baby formula is subject to the recall, look on the bottom of the container for a product code that includes eight numbers or letters.
 
Then go to this website – www.similac.com/recall – where you can type in the code to see if your baby formula is on the list.  If you have further questions, or need additional assistance, please contact an Alimentum Recall Lawyer today for free to see if you are eligible for a ​Alimentum Baby Formula Recall Lawsuit.

The recalled baby formula products contain bacteria that, if ingested, can cause a serious, life-threatening infection in young children. Any family that has Abbott products in their home should dispose of them and find a safer alternative for their children, one that doesn’t jeopardize their health and wellbeing. Although there are only four cases of infections, it’s best to avoid the products entirely to ensure your child's safety. If your child consumed recalled baby formula and became ill, contact us about a ​Alimentum Baby Formula Recall Lawsuit. 

​Cronobacter sakazakii is a bacteria commonly found in dry environments, like baby formula, and can cause stomach issues as well as urinary tract infections in people of all ages. However, when it’s ingested by a child two months or younger, it can result in more serious infections, like sepsis and meningitis. If your child exhibits any of the following symptoms after consuming a dry food product, you should seek medical treatment to ensure their safety:

• Fever
• Unusual patterns of crying
• Abnormally low energy
• Difficulty or refusal to eat

 
On the other hand, Salmonella Newport causes symptoms of foodborne illness, such as diarrhea, intestinal pressure, and vomiting. This type of bacteria is significantly more dangerous to children under three months of age, and an infant who’s infected with Salmonella Newport will exhibit the same symptoms as Cronobacter sakazakii.

If you notice that your child is exhibiting any of the symptoms mentioned above after consuming a powdered baby formula product, it is best to bring them to a trusted medical professional for a second opinion. The signs of a Cronobacter sakazakii or Salmonella Newport infection are very vague, and the behavior your child is showing could just be a coincidence rather than a severe diagnosis. However, you do not want to leave that up to chance, and by seeking medical attention sooner rather than later, you can protect your child from the consequences of an infection that has gone too far. 

​If your baby was hospitalized after using Alimentum Recalled Baby Formula purchased after August 2021, call an Alimentum Recall Lawyer about an Alimentum Baby Formula Recall Lawsuit today and see what an Alimentum Recall Lawyer can do for you.
 
​Contact Alimentum Recall Lawyer, Timothy L. Miles, today for a free case evaluation to see if you are eligible for the Alimentum Baby Formula Recall Lawsuit.

​The government affords certain protections for whistleblowers. The FCA provides protection against retaliation: Whistleblowers may not be harassed, threatened, demoted, fired, or otherwise discriminated against because of their decision to come forward. The Whistleblower Protection Act prohibits federal agencies from firing, demoting, and blacklisting federal employees who become whistleblowers as well as other forms of retaliation including reducing pay, change of duties, or reassignments.  Under the Whistleblower Protection Act, qui tam relators have the right to protections such as reinstatement if terminated or demoted, back pay, as well as compensatory damages. Read below for answers to five frequently asked questions about the Whistleblower Protection Act.

​The WPA provides protections for whistleblowers who work for the federal government. One very important exception is that the Act specifically excludes whistleblowers in the intelligence community and those who work for the FBI.

​The Intelligence Community Whistleblower Protection Act of 1998, as well as the Intelligence Authorization Act for Fiscal Year 2014 and Presidential Directive 19 all provide protections for whistleblowers employed by the intelligence community. Additionally, FBI whistleblowers are protected from retaliation for making a protected disclosures under U.S. Code § 2303 as well as the FBI Whistleblower Protection Enhancement Act of 2016. 

​There is no statute of limitations under the Whistleblower Protection Act.  Whistleblower lawsuits can be filed at any time with the Office of the Special Counsel.

​There is no statute of limitations under the Whistleblower Protection Act.  Whistleblower lawsuits can be filed at any time with the Office of the Special Counsel.

​​Complaints under the WPA are resoled by the Merit System Protection Board (MSPB) is a quasi-judicial agency established in 1978 to adjudicate whistleblower lawsuits. The primary mission of the MSPB is to “protect the merit system principles and promote an effective federal workplace free of prohibited personnel practices.” There are three members on the panel who are appointed by the President and confirmed by the Senate. Two of the three members must be of the President’s own political party, while the third must be of the opposing party. Terms are for seven years.

​If you have knowledge of fraud against or by the federal government, contact Nashville whistleblower attorney Timothy L. Miles. The consultation is free and confidential.  Just call (855) Tim-M-Law. Please also visit our Resources center which provides a wealth of whistleblower information. Call today and see what a whistleblower attorney can do for you.

​A whistleblower is anyone who has and reports insider knowledge of illegal activities occurring in an organization. Whistleblowers can be employees, suppliers, contractors, clients, or any individual who becomes aware of illegal business activities.​ If you have knowledge of a person or company attempting to defraud the federal government, and you come forward with this information, you could be receive a whistleblower award for your courage and blowing the whistle by filing a Whistleblower Lawsuit. Contact Nashville Whistleblower Attorney Timothy L. Miles today for a free case evaluation, you may be eligible for a whistleblower award. Read on for the answers to three frequently asked questions.

Qui tam is a provision in the False Claims Act (FCA) that allows private citizens with evidence of fraud perpetrated against the federal government to sue the wrongdoer on behalf of the U.S. government. These citizens are rewarded with a substantial share in any financial recovery that’s made (typically 15-30% of the total amount).

The qui tam provision was enacted to encourage private citizens to come forward with information about entities defrauding federal programs, thus allowing the government to recoup stolen funds. Qui tam lawsuits differ from other types of lawsuits, such as personal injuries, in that the person bringing the suit is not the one who has been directly harmed.

Any person with information about fraud against the government – an employee, contractor, competitor, or someone else – can bring a qui tam lawsuit.
​
If you have information about fraud against the U.S. government, contact Whistleblower Attorney Timothy L. Miles, a top-rated attorney in Nashville.  He can help you determine if you have a case, and securely walk you through the whistleblower process.

The government affords certain protections for whistleblowers. The FCA provides protection against retaliation: Whistleblowers may not be harassed, threatened, demoted, fired, or otherwise discriminated against because of their decision to come forward. The Whistleblower Protection Act prohibits federal agencies from firing, demoting, and blacklisting federal employees who become whistleblowers as well as other forms of retaliation including reducing pay, change of duties, or reassignments.  Under the Whistleblower Protection Act, qui tam relators have the right to protections such as reinstatement if terminated or demoted, back pay, as well as compensatory damages.
​
​If you have been treated unjustly because you spoke out, contact Nashville whistleblower attorney Timothy L. Miles, you can file a lawsuit against your employer seeking damages including reinstatement (if you were fired) and back pay. Even if your claim turns out to be unsubstantiated, you are protected against retaliation provided your claim was made in good faith. These protections for whistleblowers are meant to encourage whistleblowers to come forward without fear of retaliation.

​Government workers can also blow the whistle on their own government and receive a whistleblower award. The Whistleblower Protection Act is a federal law that provides these individuals with protection for disclosing various acts of unlawful and unethical behavior on the part of the U.S. government: 

• Violations of the law, rules, or regulations
• Abuse of authority
• Gross waste of funds
• Gross mismanagement
• Substantial danger to public health or safety

If you are a federal employee who has uncovered possible fraud by the federal government and you have endured punishment as a result (e.g., demotion, pay cut, firing, or harassment), contact us.  We can review your case in a free, no-risk evaluation. Contact us today, you may be entitled to a whistleblower award.

​If you have knowledge of fraud against or by the federal government, contact Nashville whistleblower attorney Timothy L. Miles. The consultation is free and confidential. Contact us today (855) Tim-M-Law. Please also visit our Resources center which provides a wealth of whistleblower information. Call today and see what a whistleblower attorney can do for you.

On February 27, 2012 Abbott Laboratories, Inc. “(Abbott”) announced it was recalling powder infant formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Michigan, one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas. Products made at this facility can be found across the U.S. and were likely exported to other countries as well. Canadian health officials have also issued a recall warning.
​
​Abbott is recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.  The Company said its investigation is ongoing. Read on to learn more about the Infant Formula Recall Lawsuit.